Targeted next generation sequencing and family survey enable correct genetic diagnosis in CRX associated macular dystrophy - a case report

BMC Ophthalmol. 2021 Apr 9;21(1):168. doi: 10.1186/s12886-021-01919-1.

Abstract

Background: We present 3 members of a family with macular dystrophy, originally diagnosed as Stargardt disease, with a significantly variable age at onset, caused by a heterozygous mutation in CRX.

Case presentation: A 43-year-old female with bull's eye maculopathy, whose sister was diagnosed with Stargardt disease previously at another centre, was found to have a single ABCA4 variant. Further examination of the family revealed that the asymptomatic father was also affected, indicating a dominant pattern of inheritance. In addition, the ABCA4 variant was not identified in the sister originally diagnosed with Stargardt disease. Next generation sequencing identified a heterozygous c.121C > T, p.R41W missense mutation in CRX in all 3 affected members.

Conclusions: We describe a common phenotype, but with variable age at onset, with autosomal dominant inheritance and reduced penetrance in a family found to have a pathogenic sequence variant in CRX. This illustrates the importance of panel based molecular genetic testing accompanied by family studies to establish a definitive diagnosis.

Keywords: ABCA4 sequence variant, mutation; CRX; Macular dystrophy; Next generation sequencing; Phenotype/genotype, reduced penetrance, family survey; Retina.

Publication types

  • Case Reports

MeSH terms

  • ATP-Binding Cassette Transporters / genetics
  • Adult
  • Female
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Macular Degeneration* / diagnosis
  • Macular Degeneration* / genetics
  • Mutation
  • Pedigree
  • Phenotype
  • Retinal Dystrophies*
  • Stargardt Disease

Substances

  • ABCA4 protein, human
  • ATP-Binding Cassette Transporters